Mesothelioma affects mostly older individuals who have been occupationally exposed to
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …

Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour. In Great
Britain, the incidence in males is 3.4/100 000, in France it is 2.3/100 000 and in the …

Malignant pleural mesothelioma (MPM) is a rare malignancy with few treatment options.
Recent advances have led to US Food and Drug Administration approvals and changes in …

Introduction Left untreated, malignant pleural mesothelioma (MPM) is associated with
uniformly poor prognosis. Better survival has been reported with surgery-based …

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer that arises from the
mesothelial surface of the pleural and peritoneal cavities, the pericardium, and rarely, the …

Abstract On March 28–29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy
Steering Committee, International Association for the Study of Lung Cancer, and …

Objective To evaluate a new protocol of accelerated hemithoracic intensity-modulated
radiation therapy (IMRT) followed by extrapleural pneumonectomy (EPP) for patients with …

Background A novel approach for managing malignant pleural mesothelioma, surgery for
mesothelioma after radiotherapy (SMART), consisting of a short accelerated course of high …